Showing results (141-150 of 220) with videos related to

Sort By:
Pageof 22
Metabolism: Clinical and Experimental|May 1, 1984
Decreases in serum high-density-lipoprotein cholesterol and total cholesterol resulting from naturally produced and recombinant DNA-derived leukocyte interferonsR M Dixon, E C Borden, N L Keim, et al.
Journal of the National Cancer Institute|November 15, 1989
Randomized phase II-III trial of combination beta and gamma interferons and etoposide and cisplatin in inoperable non-small cell cancer of the lungJ H Schiller, B Storer, R Dreicer, et al.
Cancer Treatment Reports|August 1, 1979
Phase II evaluation of diglycoaldehyde, VP-16-213, and the combination of methyl-CCNU and beta-2'-deoxythioguanosine in previously treated patients with colorectal cancer: an Eastern Cooperative Oncology Group study (EST-1275)H O Douglass, P T Lavin, J T Evans, et al.
Surgery|May 1, 1979
Chemotherapy of gastric and pancreatic carcinoma: a controlled evaluation of combinations of 5-fluorouracil with nitrosoureas and "lactones"C G Moertel, P Engstrom, P T Lavin, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 5, 2001
Phase II trial of dacarbazine (DTIC) in advanced pancreatic islet cell carcinoma. Study of the Eastern Cooperative Oncology Group-E6282R K Ramanathan, A Cnaan, R G Hahn, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|January 1, 1982
A randomized trial of postoperative five-versus three-drug chemotherapy after mastectomy: a Cancer and Leukemia Group B (CALGB) studyR B Weiss, D C Tormey, F Holland, et al.
Cancer Research|March 1, 1981
Clinical studies of a fast homoarginine-sensitive alkaline phosphatase in patients with cancerT E Davis, L Kahan, D C Tormey, et al.
Cancer|October 1, 1982
Comparison of induction chemotherapies for metastatic breast cancer. An Eastern Cooperative Oncology Group TrialD C Tormey, R Gelman, P R Band, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1993
Adjuvant tamoxifen versus placebo in elderly women with node-positive breast cancer: long-term follow-up and causes of deathF J Cummings, R Gray, D C Tormey, et al.
Investigational New Drugs|July 30, 1999
PALA versus streptozotocin, doxorubicin, and MeCCNU in the treatment of patients with advanced pancreatic carcinomaR S Witte, L M Ryan, A J Schutt, et al.
Pageof 22